Biblioteca Digital

898 resultados para prostate cancer, cPLA2-a, eicosanoids, angiogenesis

Androgen receptor and caveolin-1 in prostate cancer

Relevância:

100.00% 100.00%

Publicador:

Kallikrein 4 is a Potential Mediator of Cellular Interactions between Cancer Cells and Osteoblasts in Metastatic Prostate Cancer

Relevância:

100.00% 100.00%

Publicador:

Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer

Relevância:

100.00% 100.00%

Publicador:

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

Relevância:

100.00% 100.00%

Publicador:

FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase

Relevância:

100.00% 100.00%

Publicador:

Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis

Relevância:

100.00% 100.00%

Publicador:

Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways

Relevância:

100.00% 100.00%

Publicador:

Plant derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo

Relevância:

100.00% 100.00%

Publicador:

MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer

Relevância:

100.00% 100.00%

Publicador:

The propeptide mediates formation of stromal stores of PROMIC-1: Role in determining prostate cancer outcome

Relevância:

100.00% 100.00%

Publicador:

Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target

Relevância:

100.00% 100.00%

Publicador:

A novel model of bone-metastatic prostate cancer in immunocompetent mice

Relevância:

100.00% 100.00%

Publicador:

Orphan nuclear receptor estrogen-related receptor-(beta) suppresses in vitro and in vivo growth of prostate cancer cells via p21WAF1(sol) CIP1 induction and as a potential therapeutic target in prostate cancer

Relevância:

100.00% 100.00%

Publicador:

Which drug combination for hormone-refractory prostate cancer?

Relevância:

100.00% 100.00%

Publicador:

Innovative biomarkers for prostate cancer early diagnosis and progression

Relevância:

100.00% 100.00%

Publicador:

«
1
2
3
4
5
6
7
8
...
59
60
»